COGT icon

Cogent Biosciences
COGT

Overview Fund Activity

73 hedge funds and large institutions have $299M invested in Cogent Biosciences in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 9 closing their positions.

Holders
73
Holders Change
+4
Holders Change %
+5.8%
% of All Funds
1.28%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
14
Increased
18
Reduced
19
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VC
1
Vivo Capital
California
$12M
2
CC
2
Commodore Capital
New York
$16.1M
3
SCM
3
Silverarc Capital Management
Massachusetts
$5.7M
4
MWNA
4
Marshall Wace North America
New York
$2.75M
5
PIM
5
Platinum Investment Management
Australia
$8.26M

Top Sellers

1
HA
1
HHLR Advisors
Cayman Islands
$0
2
Invesco
2
Invesco
Georgia
$102K
3
TCM
3
Tekla Capital Management
Massachusetts
$0
4
LGM
4
Logos Global Management
California
$7.78M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$8.46M
Name Holding Trade Value Shares
Change 		Shares
Change %
SAM
76
Sectoral Asset Management
Quebec, Canada
– -$219K -27,000 Closed
Jane Street
77
Jane Street
New York
– -$196K -24,192 Closed
QSS
78
Quantitative Systematic Strategies
Florida
– -$182K -22,474 Closed
LPL Financial
79
LPL Financial
California
– -$122K -15,000 Closed
PHK
80
Point72 Hong Kong
Hong Kong
– -$12K -1,508 Closed
Bank Julius Baer & Co
81
Bank Julius Baer & Co
Switzerland
– -$1K -123 Closed
1 2 3
4